Alexander Dobrovic

Credit Name
Alexander Dobrovic
Full Name
Dobrovic, Alexander
 
 
Twitter
Loading... 2 0 20 0 false
Loading... 3 0 20 0 false

Publications

Refined By:
Author:  John, Thomas
Author:  Arulananda, Surein

Results 1-5 of 5 (Search time: 0.005 seconds).

Publication YearTitleAuthor(s)
1May-2019Standard dose osimertinib for erlotinib refractory T790M-negative EGFR-mutant non-small cell lung cancer with leptomeningeal disease.Arulananda, Surein; Do, Hongdo; Rivalland, Gareth; Loh, Zoe ; Musafer, Ashan; Lau, Eddie ; Mitchell, Paul; Dobrovic, Alexander ; John, Thomas 
224-Apr-2019BCL-XL and MCL-1 are the key BCL-2 family proteins in melanoma cell survival.Lee, Erinna F; Harris, Tiffany J ; Tran, Sharon; Evangelista, Marco; Arulananda, Surein; John, Thomas ; Ramnac, Celeste; Hobbs, Chloe; Zhu, Haoran; Gunasingh, Gency; Segal, David; Behren, Andreas; Cebon, Jonathan S ; Dobrovic, Alexander ; Mariadason, John M ; Strasser, Andreas; Rohrbeck, Leona; Haass, Nikolas K; Herold, Marco J; Fairlie, W Douglas
3Feb-2018In Reply to Leone.Do, Hongdo; Arulananda, Surein; John, Thomas ; Dobrovic, Alexander 
42018Mismatch repair protein defects and microsatellite instability in malignant pleural mesothelioma.Arulananda, Surein; Thapa, Bibhusal ; Walkiewicz, Marzena; Zapparoli, Giada V; Williams, David S ; Dobrovic, Alexander ; John, Thomas 
5Nov-2017Combination Osimertinib and Gefitinib in C797S and T790M EGFR-Mutated Non-Small Cell Lung Cancer.Arulananda, Surein; Do, Hongdo; Musafer, Ashan; Mitchell, Paul L R ; Dobrovic, Alexander ; John, Thomas